CN Patent

CN111321200A — 一种细胞外abl1激酶活性检测试剂盒及其应用

Assigned to Guangzhou Andisheng Bio Medicine Technology Co ltd · Expires 2020-06-23 · 6y expired

What this patent protects

本发明公开了一种细胞外ABL1激酶活性检测试剂盒，包括以下试剂：ATP、ABL1底物多肽、反应缓冲液，以及ABL1蛋白或ABL1激酶结构域(PTK)对应的多肽片段。本发明ABL1激酶活性检测试剂盒操作简便、有效，可以在细胞外高通量地检测ABL1激酶的活性，从而用于大规模地筛选ABL1激酶活性的抑制剂。

USPTO Abstract

本发明公开了一种细胞外ABL1激酶活性检测试剂盒，包括以下试剂：ATP、ABL1底物多肽、反应缓冲液，以及ABL1蛋白或ABL1激酶结构域(PTK)对应的多肽片段。本发明ABL1激酶活性检测试剂盒操作简便、有效，可以在细胞外高通量地检测ABL1激酶的活性，从而用于大规模地筛选ABL1激酶活性的抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111321200A
Jurisdiction
CN
Classification
—
Expires
2020-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Andisheng Bio Medicine Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.